Nimodep-30 (Nimodipine Tablet) 30mg

Nimodep-30 (Nimodipine 30mg) is a calcium channel blocker used to improve neurological outcomes after subarachnoid hemorrhage. This 100-tablet pack provides ambient-stable oral tablets for consistent daily use. Nimodipine 30mg tablets are prescribed to support blood flow in the brain during recovery. Ideal for patients managing post-stroke care with reliable supply.

Strength

30mg

Pack Size

100s

Storage

Ambient

Manufacturer / TM Owner

Johnlee Pharmaceuticals Pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nimodep-30 (Nimodipine 30mg) is commonly used to help improve neurological recovery following a subarachnoid hemorrhage by supporting blood flow in the brain. It is prescribed to reduce the risk of complications related to reduced cerebral perfusion. Patients may take Nimodipine 30mg tablets as part of a broader post-stroke care plan to support stable blood vessel function.

Side Effects

Nimodep-30 (Nimodipine 30mg) works by relaxing blood vessels in the brain, which may help maintain steady blood flow during recovery. Common effects include mild dizziness or flushing as the body adjusts to the medication. Some users report a feeling of warmth or lightheadedness, especially when starting treatment.

Precautions & Warnings

Store Nimodep-30 (Nimodipine 30mg) at room temperature away from moisture and direct light. Keep out of reach of children and pets to prevent accidental ingestion. Use only as directed by a healthcare professional and report any unusual symptoms promptly. Avoid crushing or splitting tablets unless advised by a medical provider.

Avoid Interactions

Nimodep-30 (Nimodipine 30mg) may interact with other medications that affect blood pressure or heart rhythm, including certain antihypertensives and CYP3A4 inhibitors. Grapefruit products can increase nimodipine levels; avoid consuming grapefruit while taking this medication. Alcohol may enhance dizziness or lightheadedness when combined with nimodipine.

Frequently Asked Questions

Nimodipine 30mg is used to improve neurological outcomes after a subarachnoid hemorrhage by supporting blood flow in the brain.

Store Nimodep-30 at room temperature, away from moisture and light, and keep it out of reach of children.

Avoid grapefruit or grapefruit juice while taking Nimodipine 30mg, as it may increase the medication's effects.

Nimodipine 30mg is typically prescribed for short-term use after a subarachnoid hemorrhage; consult your healthcare provider for guidance.

Common side effects may include dizziness, flushing, or a feeling of warmth, especially when starting treatment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.